Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04697160 · ClinicalTrials.gov registry record
Observational Retrospective Cohort Study of Systemic Therapies for R/R DLBCL
A clinical trial, sponsored by MorphoSys.
- Completed
- Registry status
- 3,573
- Enrollment target
NCT04697160 is a clinical trial that has completed, run by MorphoSys. The registered enrollment target is 3,573 participants.
The verdict
NCT04697160 has completed, sponsored by MorphoSys.
- COMPLETED
- Registry status
- 3,573 participants
- Enrollment target
Study Summary
To compare the efficacy outcomes of the L-MIND cohort with the effectiveness in a matched patient population treated with systemic NCCN/ESMO guideline listed regimens administered in routine clinical care.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,573 participants |
| Start Date | 2020-04-01 |
| Est. Completion | 2021-05-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04697160
The ClinicalTrials.gov registry entry for NCT04697160 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3,573 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MorphoSys, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04697160 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04697160 about?
NCT04697160 is a clinical study titled "Observational Retrospective Cohort Study of Systemic Therapies for R/R DLBCL". To compare the efficacy outcomes of the L-MIND cohort with the effectiveness in a matched patient population treated with systemic NCCN/ESMO guideline listed regimens administered in routine clinical care.
What is the current status of trial NCT04697160?
This trial is currently completed. The enrollment target is 3,573 participants. The study started on 2020-04-01. Estimated completion is 2021-05-07.
Who is sponsoring clinical trial NCT04697160?
This trial is sponsored by MorphoSys, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.